Tectonic Therapeutic (TECX) Institutional Ownership $19.00 +0.35 (+1.88%) (As of 09/18/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tectonic Therapeutic (NASDAQ:TECX)CurrentInstitutional OwnershipPercentage62.63%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$17.56MNumber ofInstitutional Sellers(last 12 months)0 Get TECX Insider Trade Alerts Want to know when executives and insiders are buying or selling Tectonic Therapeutic stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TECX Institutional Buying and Selling by Quarter Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Tectonic Therapeutic Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Affinity Asset Advisors LLC58,331$961K0.1%N/A0.130% 8/14/2024 Farallon Capital Management LLC431,010$7.10M0.0%N/A0.960% 8/9/2024 Renaissance Technologies LLC89,029$1.47M0.0%N/A0.198% 8/9/2024 Atlas Venture Life Science Advisors LLC378,447$6.23M0.7%N/A0.843% 8/6/2024 Acadian Asset Management LLC109,629$1.80M0.0%N/A0.244% (Data available from 1/1/2016 forward) TECX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TECX shares? During the previous two years, the following institutional investors and hedge funds held shares of Tectonic Therapeutic shares: Farallon Capital Management LLC ($7.10M), Atlas Venture Life Science Advisors LLC ($6.23M), Acadian Asset Management LLC ($1.80M), and Renaissance Technologies LLC ($1.47M), Affinity Asset Advisors LLC ($961K).Learn more on TECX's institutional investors. What percentage of Tectonic Therapeutic stock is owned by institutional investors? 62.63% of Tectonic Therapeutic stock is owned by institutional investors. Learn more on TECX's institutional investor holdings. Which institutional investors have been buying Tectonic Therapeutic stock? The following institutional investors have purchased Tectonic Therapeutic stock in the last 24 months: Farallon Capital Management LLC ($431.01K), Atlas Venture Life Science Advisors LLC ($378.45K), Acadian Asset Management LLC ($109.63K), Renaissance Technologies LLC ($89.03K), and Affinity Asset Advisors LLC ($58.33K). How much institutional buying is happening at Tectonic Therapeutic? Institutional investors have bought a total of 1,066,446 shares in the last 24 months. This purchase volume represents approximately $17.56M in transactions. Related Companies: Biohaven Institutional Ownership HUTCHMED Institutional Ownership Rhythm Pharmaceuticals Institutional Ownership MoonLake Immunotherapeutics Institutional Ownership Merus Institutional Ownership Xenon Pharmaceuticals Institutional Ownership Dyne Therapeutics Institutional Ownership SpringWorks Therapeutics Institutional Ownership MorphoSys Institutional Ownership Morphic Institutional Ownership This page (NASDAQ:TECX) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredKamala Harris To Tank the Market?URGENT ELECTION MELTDOWN WARNING From the former CIA advisor who predicted President Trump’s win in 2016…Paradigm Press | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tectonic Therapeutic Please log in to your account or sign up in order to add this asset to your watchlist. Share Tectonic Therapeutic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.